What Milestone Pharmaceuticals Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 13 |
| Total trades | 0 | 24 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 827,000 |
| Disposed | 0 | 548,079 |
| Net activity | +0 | +278,921 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Oliveto Joseph | President and CEO | Apr 16 | Open-market sale · S | −36,500 | $2.26 | −$82.5K | 446,244 |
| Hasija Amit | CFO & EVP of Corp. Development | Jan 26 | Open-market sale · S | −12,245 | $1.93 | −$23.6K | 99,848 |
| Hasija Amit | CFO & EVP of Corp. Development | Jan 26 | Exercise / conversion · M | +20,100 | — | — | 112,093 |
| Muller Lorenz | Chief Commercial Officer | Jan 26 | Open-market sale · S | −11,180 | $1.93 | −$21.6K | 205,406 |
| Muller Lorenz | Chief Commercial Officer | Jan 26 | Exercise / conversion · M | +20,100 | — | — | 216,586 |
| Nelson Jeffrey Edward | Chief Operating Officer | Jan 26 | Open-market sale · S | −12,245 | $1.93 | −$23.6K | 49,848 |
| Nelson Jeffrey Edward | Chief Operating Officer | Jan 26 | Exercise / conversion · M | +20,100 | — | — | 62,093 |
| Bharucha David | Chief Medical Officer | Jan 26 | Open-market sale · S | −12,245 | $1.93 | −$23.6K | 113,181 |
| Bharucha David | Chief Medical Officer | Jan 26 | Exercise / conversion · M | +20,100 | — | — | 125,426 |
| Oliveto Joseph | President and CEO | Jan 26 | Open-market sale · S | −34,523 | $1.93 | −$66.6K | 482,744 |
| Oliveto Joseph | President and CEO | Jan 26 | Exercise / conversion · M | +66,600 | — | — | 517,267 |
| Oliveto Joseph | President and CEO | Jan 08 | Open-market sale · S | −43,000 | $2.25 | −$96.8K | 303,721 |
| Oliveto Joseph | President and CEO | Jan 07 | Open-market sale · S | −500 | $2.25 | −$1.13K | 346,721 |
| Hasija Amit | CFO & EVP of Corp. Development | Dec 15 | Open-market sale · S | −58,007 | $2.32 | −$135K | 91,993 |
| Muller Lorenz | Chief Commercial Officer | Dec 15 | Open-market sale · S | −53,566 | $2.32 | −$124K | 196,486 |
| Nelson Jeffrey Edward | Chief Operating Officer | Dec 15 | Open-market sale · S | −58,007 | $2.32 | −$135K | 41,993 |
| Bharucha David | Chief Medical Officer | Dec 15 | Open-market sale · S | −58,007 | $2.32 | −$135K | 105,326 |
| Oliveto Joseph | President and CEO | Dec 15 | Open-market sale · S | −133,054 | $2.32 | −$309K | 450,667 |
| Hasija Amit | CFO & EVP of Corp. Development | Dec 12 | Grant / award · A | +100,000 | — | — | 150,000 |
| Muller Lorenz | Chief Commercial Officer | Dec 12 | Grant / award · A | +100,000 | — | — | 250,052 |
Loading...